Question 1

What is REGN's ST Score?

Accepted Answer

Regeneron Pharmaceuticals, Inc. (REGN) has an ST Score of 55.1 out of 100, an overall grade of B-. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Question 2

Is REGN a buy, sell, or hold?

Accepted Answer

Wall Street's consensus rating on REGN is Buy based on 49 analyst ratings. Our own ST Score grades it B- (55.1/100). This is data, not investment advice — always do your own research.

Question 3

What is REGN's valuation grade?

Accepted Answer

Regeneron Pharmaceuticals, Inc. (REGN) earns a valuation grade of D-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

Question 4

What is REGN's growth grade?

Accepted Answer

Regeneron Pharmaceuticals, Inc. (REGN) earns a growth grade of B-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

Question 5

What is REGN's profitability grade?

Accepted Answer

Regeneron Pharmaceuticals, Inc. (REGN) earns a profitability grade of A+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

Question 6

What is REGN's financial strength grade?

Accepted Answer

Regeneron Pharmaceuticals, Inc. (REGN) earns a financial strength grade of D, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

Question 7

What is the analyst price target for REGN?

Accepted Answer

The average analyst price target for Regeneron Pharmaceuticals, Inc. (REGN) is $827.71 from 49 analysts, which is +0.0% versus the recent price of $803.90.

Question 8

What is REGN's Piotroski score?

Accepted Answer

Regeneron Pharmaceuticals, Inc. (REGN) has a Piotroski F-Score of 7 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.

Regeneron Pharmaceuticals, Inc. (REGN) Analyst Ratings & Price Targets

What are stock analyst ratings and what do they mean?

What is the average analyst price target for REGN?

Are stock analyst ratings useful?

How often are REGN's analyst ratings updated?

What is the current Regeneron Pharmaceuticals, Inc. (REGN) stock price?

What sector and industry does REGN operate in?

What is REGN's market cap?

How many employees does REGN have?